Patient-Reported Outcomes in Evaluating Lorecivivint (SM04690) for Moderate to Severe Knee Osteoarthritis (STRIDES-1)
Completed · Phase 3 · Has a placebo group
Conditions studied: Knee Osteoarthritis
In brief
This phase 3 study is a multicenter, randomized, double-blind, placebo-controlled study of lorecivivint injected intraarticularly (IA) into the target knee (most painful) joint of moderately to severely symptomatic osteoarthritis (OA) subjects at a single dose of 0.07 mg lorecivivint per 2 mL injection. This study will utilize patient reported outcomes (PROs) to evaluate the safety and efficacy of lorecivivint.
Key facts
- Study ID
- NCT04385303
- Run by
- Biosplice Therapeutics, Inc.
- People needed
- 496
- Starts
- 2020-05-26
- Expected to finish
- 2021-09-08
- Last updated by the study team
- 2026-02-04
Who can join
Age: 40 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Research Site — Birmingham, Alabama, United States
- Research Site — Mobile, Alabama, United States
- Research Site — Phoenix, Arizona, United States
- Research Site — Phoenix, Arizona, United States
- Research Site — Tucson, Arizona, United States
- Research Site — Little Rock, Arkansas, United States
- Research Site — Anaheim, California, United States
- Research Site — Beverly Hills, California, United States
- Research Site — Canoga Park, California, United States
- Research Site — Garden Grove, California, United States
- Research Site — La Mesa, California, United States
- Research Site — Norco, California, United States
- Research Site — Pomona, California, United States
- Research Site — San Diego, California, United States
- Research Site — Santa Monica, California, United States
- Research Site — Thousand Oaks, California, United States
- Research Site — Westminster, California, United States
- Research Site — Boulder, Colorado, United States
- Research Site — Hamden, Connecticut, United States
- Reserach Site — Clearwater, Florida, United States
- Research Site — Edgewater, Florida, United States
- Research Site — Gulf Breeze, Florida, United States
- Research Site — Miami, Florida, United States
- Research Site — Miami, Florida, United States
- Research Site — Birmingham, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.